News|Articles|February 17, 2024
Global Use of Nonprescription Weight-Loss Products Among Adolescents: 5 Key Takeaways
Author(s)Erin O'Brien
What does recent research tell us about use of nonprescription weight-loss products among teens?
Advertisement
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Approves sNDA of Caplyta for the Prevention of Relapse in Schizophrenia
2
The Latest Data on Psychedelic DT120 ODT With Daniel R. Karlin, MD, MA
3
Accelerated FDA Action for Psychedelics: Insights From Daniel R. Karlin, MD, MA
4
FDA Fast-Tracks Psychedelic Therapies for Depression, PTSD, and Alcohol Use Disorder
5